Cervical cancer

Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix Cancer

Who can joinWomen

Age18–90 years

Kind of studyObservational: no new treatment

What it testsWatches and records only

The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.

Where to go

1 hospital in India taking patients for this trial.

Advanced Centre of Treatment Research and Education In Cancer, Tata Memorial CentreNavi Mumbai, MaharashtraDirections ↗

Registry summary (technical)

Retrospective study utilizing patient data to develop and validate Machine Learning application. Available imaging data sets of patients who have completed treatment will be used to develop Normal tissue complication probability and Tumour control probability Hypothesis Integrating existing radiation treatment information, quantitative imaging and patient outcome data from completed and ongoing clinical trials will allow development of knowledge based systems for efficient treatment delivery and allow selection of patients for intensified treatment approaches in cervix cancer.

Sponsor: Tata Memorial Hospital
NCT05102240 on ClinicalTrials.gov · CTRI number CTRI/2021/08/035810
Last updated on the registry 20 Feb 2026 · read by us 20 Oct 2026

Cervical cancer

Where to go

Need help reaching the trial team? Write to us.